Bill Ackman says he has evidence that Allergan, Inc. (NYSE:AGN) officials knowingly delivered false and misleading information to their investors regarding the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) takeover bid. He just hasn’t personally seen the evidence yet. Speaking at a conference in Toronto, Ackman told reporters “We believe they put those statements out [and that] they knew they were false at the time that they made them.” Ackman refers to Allergan’s attempt to describe Valeant takeover bid Ackman is referring to attempts by Allergan, Inc. (NYSE:AGN) to describe the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) takeover bid and its business model…
Ackman Has Evidence Of Misleading Allergan Statements, He Just Hasn't Seen It Yet
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.